OpenAlex
PricingAboutJobs
Log inGet started
Work

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease

HTML

Year: 2012
Type: review
Source: Current Opinion in Pharmacology
DOI: 10.1016/j.coph.2012.06.008
Authors: Apostolos Kontzias, Alexander Kotlyar, Arian Laurence, Paul Changelian, John J O'Shea
Institutions: National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Infinity Pharmaceuticals (United States)
Language: English

Topic: Cytokine Signaling Pathways and Interactions
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: JAK inhibitors, Janus kinase, cytokine signaling, cytokine receptors, cancer therapy, autoimmune disease, inflammatory diseases, signal transduction
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Award: Targeting Janus kinases in the treatment of autoimmune disease
OpenAlex ID: W1991660645
FWCI: 1.754
Cites: 63
Cited by: 246
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms